ipamorelin with cjc-1295 Tesamorelin & (Mod GRF 1-29) & (12mg) Buy CJC-1295 & Ipamorelin Blend

The Phase 2 trial published in the New England Journal of Medicine showed up to 24.2% weight loss at 48 weeks

Ipamorelin is regarded as one of the mildest growth hormone releasing peptides in terms of negative side effects

Treatment follows the data

All tesamorelin products are intended for laboratory research use only and not for human consumption

Amplified Growth Hormone Pulsatility : By combining a GHRH analog (Tesamorelin) with a ghrelin receptor agonist (Ipamorelin), this blend has been observed to produce synergistic GH release through two complementary pathways

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc